Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Olopatadine Hydrochloride Capsules

Approval Number

国药准字H20174034

Company重庆药友制药有限责任公司

Registration Date

May 11, 2022

Previous Approval Numbers

国药准字H20174034

Drug Information

Generic Name

盐酸奥洛他定胶囊

Brand Name

备舒宁

Dosage Form

胶囊剂

Strength

5mg

Drug Type

化学药品

Registration Date

May 11, 2022

Company Information

Applicant Company

Company Name重庆药友制药有限责任公司

Company Address

重庆市渝北区人和镇星光大道100号

Manufacturing Company

Company Name重庆西南制药二厂有限责任公司

Company Address

重庆市江津区德感街道兰溪路555号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy